SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.

SCCM Pod-317 Duration of Antimicrobial Treatment for Bacteremia in Canadian Critically Ill Patients

visual bubble
visual bubble
4/14/2016

Todd Fraser, MD, speaks with Nick Daneman, MD, about the article, “Duration of Antimicrobial Treatment for Bacteremia in Canadian Critically Ill Patients,” published in Critical Care Medicine. Dr. Daneman is a scientist in the Evaluative Clinical Sciences, Trauma, Emergency & Critical Care Research Program at Sunnybrook Research Institute, and Assistant Professor of Medicine at the University of Toronto in Toronto, Ontario, Canada. In this article, Dr. Daneman and coauthors discuss duration of antimicrobial treatment provided to patients who have bacteremia in ICUs, and assess pathogen/patient factors related to treatment duration and the relationship between duration and survival.

*If you are unable to play the podcast please click here to download the file.

Category: CCM Podcast

 

Disclaimer

Knowledge Area: Pharmacology